Choosing between semaglutide and tirzepatide ultimately depends on your individual needs, health goals, and how your body responds to each medication
Medical-Grade Formulations: We use only high-quality products with proven results
If you dont have enough of this protein, that means you have pernicious anemia
The timeline will depend on safety data, final trial outcomes, and regulatory review
A pharmacokinetic analysis of Retatrutide published in the Journal of Clinical Pharmacology reported a mean terminal half-life of approximately 6 days with a coefficient of variation below 30%, supporting reliable weekly dosing in primate models
Special Research Fund for Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College (YS202018) by the Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College